代表论著
(1) Human/mouse CD137 agonist, JNU-0921,effectively shrinks tumors through enhancing the cytotoxicity of CD8+ T cells in cis and in trans. Lu Liu†, Fenghua Chen†, Shan Li†, Tong Yang†, Shuzhen Chen, Yang Zhou, Zejian Lin, Guandi Zeng, Pengju Feng, Hong-Bing Shu, Qian Zhou*, Ke Ding*, Liang Chen*.Sci Adv., 2024, 23;10(34):eadp8647 DOI: 10.1126/sciadv.adp8647
(2) Discovery of Hexahydrofuro[3,2‑b] furans as New Kinase-Selective and Orally Bioavailable JAK3 Inhibitors for the Treatment of Leukemia Harboring a JAK3 Activating Mutant. Shan Li, † Hongfei Si, † Xiaojuan Song, Chong Lei, Xiaoqiang He, Jie Wang, Yiling Liu, Yang Zhou, Jian-Guo Song, Lijie Peng, Xia Tang, Shingpan Chan, Xiaomei Ren, Zhengchao Tu, Zhengqiu Li,* Zhen Wang,* Zhang Zhang* and Ke Ding*.J. Med. Chem. 2022, 65, 10674-10690.
(3) LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo. Yingqiang Liu†, Mengzhen Lai†, Shan Li†, Yanan Wang†, Fang Feng, Tao Zhang, Linjiang Tong, Mengge Zhang, Hao Chen, Yi Chen, Peiran Song, Yan Li, Gang Bai, Yi Ning, Haotian Tang, Yan Fang, Yi Chen, Xiaoyun Lu, Meiyu Geng, Ke Ding*, Ker Yu*, Hua Xie* and Jian Ding*.Cancer Science, 2022, 113, 709-720.
(4) Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFRT790M/C797S Mutants. Shan Li†, Tao Zhang†, Su-Jie Zhu†, Chong Lei, Mengzhen Lai, Lijie Peng, Linjiang Tong, Zilu Pang, Xiaoyun Lu, Jian Ding, Xiaomei Ren,* Cai-Hong Yun,* Hua Xie,* and Ke Ding*. ACS Medicinal Chemistry Letters, 2022, 13, 196-202.
(5) Palladium-Catalyzed, Silver-Assisted Direct C5-H Arylation of 3-Substituted 1,2,4-Oxadiazoles Under Microwave Irradiation. Shan Li, Penghui Wan, Jing Ai, Rong Sheng*, Yongzhou Hu* and Youhong Hu*. Adv. Synth. Catal. 2017, 359, 772-778.
获奖及荣誉
1. 2-氨基嘧啶类化合物及其药物组合物和应用,丁克;李姗;张章;司鸿飞;涂正超;任小梅;雷冲;唐霞;高悦译;陈成斌,专利号:ZL202180005255.5,授权公告日: 2024年06月18日
2. 2-吲哚酮类ERRα反向激动剂及其药物组合物和应用,丁克;李姗;彭丽洁;司鸿飞;张章;任小梅;雷冲,专利号:ZL201910894236.7,授权公告日: 2022年05月20日
3. 2-氨基嘧啶类化合物及其应用,丁克;丁健;陆小云;耿美玉;李姗;谢华;陈灏;童林江;任小梅;冯芳,专利号:ZL201980077663.4,授权公告日:2023年08月11日
4. 2-AMINOPYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF,DING, Ke; LI, Shan; ZHANG, Zhang; SI, Hongfei; TU, Zhengchao; REN, Xiaomei; LEI, Chong; TANG, Xia; GAO, Yueyi and CHAN, Shingpan,Patent number: 2021416682,Dated:26th day of April 2024
5. 靶向泛素化降解ERRα蛋白的化合物及其药用组合物和应用,丁克;彭丽洁;张振声;任小梅;张章;雷冲;李姗,专利号:ZL201811445971.1,授权公告日:2023年03月31日